口蹄疫（FMD）市场规模、份额和成长分析（按疫苗类型、动物种类、通路和地区划分）－2026-2033年产业预测

预计到 2024 年，口蹄疫 (FMD) 市场规模将达到 34.8 亿美元，到 2025 年将成长至 37.9 亿美元，到 2033 年将成长至 74.3 亿美元，在预测期（2026-2033 年）内，复合年增长率为 8.8%。

口蹄疫市场分析显示，兽用疫苗需求显着成长，主要受动物性食品消费量上升和牲畜数量增加的推动。这一趋势与牲畜和通用感染疾病的增加密切相关，而环境变化和快速全球化加剧了这一趋势。世界各国政府优先考虑对牲畜和伴侣动物采取有效的医疗控制措施，以减轻疾病爆发对国家GDP的经济影响。由于缺乏特效治疗方法且感染途径多样，疫苗接种策略的重要性凸显。随着动物产品需求的飙升，相关人员必须加大对口蹄疫防治的投入。同时，采取严格动物卫生措施的地区已成功控制了口蹄疫，从而降低了对疫苗的迫切需求。

口蹄疫（FMD）疾病市场驱动因素

动物性蛋白质和乳製品消费量的成长是口蹄疫市场的主要驱动因素。随着全球人口的成长，对畜产品的需求也随之增加，因此，应对口蹄疫的影响至关重要，因为口蹄疫可能会对畜牧业造成巨大的经济损失。为了满足这项需求，确保牲畜健康是重中之重，因为口蹄疫疫情会阻碍生产并扰乱供应链。因此，重视疾病预防和控制策略对于维护牲畜健康以及支持整个肉类和乳製品行业的成长至关重要。

口蹄疫市场限制

与口蹄疫疫苗和诊断试剂相关的经济负担构成了巨大的市场挑战，尤其是在牲畜存栏量大规模的开发中国家。采购和实施这些必要的预防措施的成本可能会限制农民和畜牧生产者获得这些措施的机会，而他们本来就面临经济困难。该地区资源和资金的匮乏进一步加剧了这种情况，使得相关人员难以实施有效的口蹄疫控制措施。因此，这些经济限制会阻碍疾病防治工作，进而影响牲畜的整体健康和生产力。

口蹄疫市场趋势

口蹄疫疫苗市场呈现显着成长趋势，尤其是在畜牧业是重要经济活动的开发中国家。这项需求激增主要得益于各国主导积极采取措施控制和预防口蹄疫疫情。随着人们对口蹄疫对牲畜健康和农业生产力影响的认识不断提高，各国政府正加大对疫苗接种计画的投入，以保护动物福利并确保粮食安全。此外，公私部门在疫苗研发和分发方面的合作也进一步推动了市场成长，反映了各方为减轻口蹄疫经济影响而做出的共同努力。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球口蹄疫疫苗市场规模（依疫苗类型和复合年增长率划分）（2026-2033 年）

• 传统疫苗
  • 氢氧化铝/皂素疫苗
  • 油性疫苗
• 紧急疫苗

全球口蹄疫（FMD）市场规模（按动物类型划分）及复合年增长率（2026-2033 年）

• 牛
• 绵羊/山羊
• 猪
• 其他动物

全球口蹄疫（FMD）市场规模（依通路划分）及复合年增长率（2026-2033 年）

• 兽医医院和诊所
• 政府机构
• 零售药房
• 网路药房

全球口蹄疫市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Boehringer Ingelheim（Germany）
• Merck Animal Health（USA）
• Zoetis（USA）
• MSD Animal Health（USA）
• Elanco Animal Health（USA）
• Ceva Sante Animale（France）
• Virbac（France）
• Indian Immunologicals Limited（India）
• Biogenesis Bago（Argentina）
• FMD Center World Reference Laboratory（UK）
• TAD Pharma GmbH（Germany）
• Vetoquinol（France）
• Phibro Animal Health Corporation（USA）
• Tiankang Bio（China）
• Ringpu Biology（China）
• CAVAC（China）
• Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna（Italy）
• Korea Animal Health Products Association（Korea）
• CZ Veterinaria（Spain）

结论与建议

FMD Disease Market size was valued at USD 3.48 Billion in 2024 and is poised to grow from USD 3.79 Billion in 2025 to USD 7.43 Billion by 2033, growing at a CAGR of 8.8% during the forecast period (2026-2033).

Market insights into foot-and-mouth disease (FMD) reveal a significant increase in the demand for veterinary vaccines, largely driven by the growing consumption of animal products and an expanding livestock population. This trend is closely linked to the rise of livestock and zoonotic diseases, exacerbated by environmental changes and rapid globalization. Governments worldwide are prioritizing effective medical practices for both livestock and companion animals to mitigate the economic impacts of disease outbreaks on national GDPs. The absence of definitive cures and multiple infection pathways underscored the critical need for vaccination strategies. As animal product demands surge, investment in FMD prevention becomes essential for stakeholders. In contrast, regions with stringent animal health measures have successfully controlled FMD, reducing the immediate necessity for vaccines.

Top-down and bottom-up approaches were used to estimate and validate the size of the FMD Disease market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

FMD Disease Market Segments Analysis

Global FMD Disease Market is segmented by Vaccine Type, Animal Type, Distribution Channel and region. Based on Vaccine Type, the market is segmented into Conventional vaccines and Emergency vaccines. Based on Animal Type, the market is segmented into Cattle, Sheep & goat, Pig and Other animals. Based on Distribution Channel, the market is segmented into Veterinary hospitals & clinics, Government institutions, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the FMD Disease Market

The increasing consumption of animal protein and dairy products serves as a significant catalyst for the FMD (Foot-and-Mouth Disease) market. As the global population continues to rise, so does the need for livestock, which makes it crucial to address the impacts of FMD, a disease that can result in substantial economic losses within the livestock sector. Ensuring the health of livestock is paramount to meeting this demand, as outbreaks of FMD can hinder production levels and disrupt supply chains. Consequently, the focus on disease prevention and management strategies becomes essential for maintaining livestock health and supporting the overall growth of the meat and dairy industries.

Restraints in the FMD Disease Market

The financial burden associated with vaccines and diagnostic tests for foot-and-mouth disease (FMD) poses a significant challenge for the market, especially in developing nations that boast substantial livestock herds. The expense involved in acquiring and administering these essential preventative measures can limit accessibility for farmers and livestock producers who may already be facing economic hardships. This situation is exacerbated by limited resources and funding in these regions, making it difficult for stakeholders to implement effective FMD control strategies. Consequently, these financial constraints can hinder efforts to manage and mitigate the spread of the disease, affecting overall livestock health and productivity.

Market Trends of the FMD Disease Market

The FMD disease market is witnessing a notable trend characterized by a rising demand for FMD vaccines, particularly in developing nations where livestock farming is a vital economic activity. This surge is largely driven by proactive government initiatives aimed at controlling and preventing foot-and-mouth disease outbreaks. As awareness of the disease's impact on livestock health and agricultural productivity grows, authorities are increasingly investing in vaccination programs to safeguard animal welfare and ensure food security. Additionally, the collaboration between public and private sectors in vaccine development and distribution is further bolstering market growth, reflecting a concerted effort to mitigate the economic repercussions of FMD.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global FMD Disease Market Size by Vaccine Type & CAGR (2026-2033)

• Market Overview
• Conventional vaccines
  • Aluminium hydroxide & saponin-based vaccines
  • Oil-based vaccines
• Emergency vaccines

Global FMD Disease Market Size by Animal Type & CAGR (2026-2033)

• Market Overview
• Cattle
• Sheep & goat
• Pig
• Other animals

Global FMD Disease Market Size by Distribution Channel & CAGR (2026-2033)

• Market Overview
• Veterinary hospitals & clinics
• Government institutions
• Retail pharmacies
• Online pharmacies

Global FMD Disease Market Size & CAGR (2026-2033)

• North America (Vaccine Type, Animal Type, Distribution Channel)
  • US
  • Canada
• Europe (Vaccine Type, Animal Type, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Vaccine Type, Animal Type, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Vaccine Type, Animal Type, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Vaccine Type, Animal Type, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Boehringer Ingelheim (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zoetis (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MSD Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elanco Animal Health (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ceva Sante Animale (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virbac (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Indian Immunologicals Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biogenesis Bago (Argentina)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FMD Center World Reference Laboratory (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TAD Pharma GmbH (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vetoquinol (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Phibro Animal Health Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tiankang Bio (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ringpu Biology (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CAVAC (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Korea Animal Health Products Association (Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CZ Veterinaria (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations